Next money there is this meeting organized by the Doherty Institute. I do not who all are speaking. However, we know that Dr. SL Neville who studies PBT2 and otitis media infections at Doherty Institute and one of the 4 inventors of the PBT2 patent Prof. CA McDevitt, the boss of Dr. Neville, is also working with PBT2 ( pneumonia and other general infections) in the same lab. So they may have a word or two in there.
If anybody can get any info from this meeting, I would be happy. I think we could perhaps know how the commercialization of PBT2 is at this moment. My understanding is that some clinical info needs to be gathered before any deal negotiation is started (???). Both Dr. Neville and Prof. McDevitt have been collecting this info for 1.5 years.
ATH Price at posting:
0.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)